key: cord-0841192-scchfryc
authors: Berger, Daniel; Gundermann, Gabrielle; Sinha, Anjana; Moroi, Morgan; Goyal, Neerav; Tsai, Anthony
title: Review of Aerosolized Hydrogen Peroxide, Vaporized Hydrogen Peroxide, and Hydrogen Peroxide Gas Plasma in the Decontamination of Filtering Facepiece Respirators
date: 2021-06-25
journal: Am J Infect Control
DOI: 10.1016/j.ajic.2021.06.012
sha: cc1812a813345d9b6331f3d1d9b021bcccfb8f1a
doc_id: 841192
cord_uid: scchfryc

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021.The pandemic has also created severe shortages of PPE, particularly of filtering facepiece respirators (FFRs). The Centers for Disease Control and Prevention (CDC) has issued recommendations to help conserve FFRs, as well as crisis standards, including four criteria required for decontamination of the traditionally single use respirators. This review is designed to provide an overview of the current literature on vaporized hydrogen peroxide (vHP), hydrogen peroxide gas plasma (HPGP), and aerosolized hydrogen peroxide (aHP) with respect to each of the four CDC decontamination criteria. Searches of PubMed and Medrxiv yielded 195 papers, of which, 79 were found to be relevant. Of those, 23 papers presented unique findings and 8 additional articles and technical papers were added to provide a comprehensive review. Overall, while there are potential concerns for all three decontamination methods, we found that vHP has the most evidence supporting its use in FFR decontamination consistent with CDC recommendation. Future research is recommended to evaluate biological inactivation and real world fit failures after FFR reuse.

Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 170 million cases worldwide with over 33.2 million cases and 594,000 deaths in the US alone as of May 31st, 2021. 1 Based on modeling released in March of 2020, the World Health Organization (WHO) estimated that 89 million medical masks would be needed for COVID-19 response each month, requiring an increase in global manufacturing of at least 40 percent. 2 Stockpiling by health systems and governments, panic buying by the public, travel and export restrictions, and nationwide lockdowns that created interruptions in an already taxed supply chain further exacerbated shortages of medical supplies including ventilators, associated consumables, and disinfection supplies. Most notably, personal protective equipment (PPE), specifically filtering facepiece respirators (FFRs), have faced severe shortages. 2 In the United States, N95 respirators are the dominant FFR used by healthcare workers and are tested according to National Institute for Occupational Safety and Health (NIOSH) standards.

They are designed to form a seal around the wearer's face and provide ≥ 95% filtration efficiency of 0.3 µm non-oily particles.

The CDC has created several recommendations to conserve N95 respirators, including the use of administrative controls to minimize both the number of individuals who require respiratory protection and patient encounters. The CDC has also developed crisis strategies only to be used when supplies of FFRs cannot match with the rate of use (the "burn rate"). These crisis strategies include the use of respirators beyond their expiration date, reuse of single use respirators for multiple patient encounters, wearing the respirators for extended wear times (extended use), and prioritizing N95 respirators for personnel at highest risk of contracting an infection, such as those performing aerosol generating procedures. 3 In the event that these crisis strategies are insufficient to meet FFR demand, the CDC has also outlined guidance for the decontamination of traditionally single-use FFRs, specifying that any technique meet the four criteria listed in Table   1 . 3   Table 1 . CDC criteria for evaluation of decontamination methods for FFR

Filtration performance is not affected after each cycle of decontamination.

Fit performance of the respirator is not affected after each decontamination cycle.

The method can inactivate viruses and bacteria.

Off-gassing of decontamination chemicals falls below the permissible range. Food and Drug Administration Staff. 5 These non-binding recommendations outlined three "Tiers" of decontamination, with Tier 1 designed for respirators and surgical masks that will be shared between HCPs, Tier 2 designed for reuse by the same HCP, and Tier 3 designed solely to reduce the bioburden on respirators that will be reused according to CDC reuse guidelines. Each of these has different microbial inactivation guidelines with Tier 1 requiring inactivation against organisms with higher levels of resistance. The Tiers described in the guidelines are summarized in Table 2 . In addition, the FDA requested companies provide information including cycle parameters and monitoring thereof, ability to meet microbial inactivation in accordance with Table 2 , compatibility with masks/respirators, number of times they can be decontaminated, and tracking and handling systems for the masks/respirators. 5 

To conduct this review, PubMed and MedRxiv were searched through October 31, 2020 to capture the most relevant published and pre-publication data. Search terms included "aerosolized hydrogen peroxide," "vaporized hydrogen peroxide," "hydrogen peroxide gas plasma," and "hydrogen peroxide plasma," "((Decontamination) OR (disinfection)) AND (PPE) AND (Hydrogen Peroxide)." Additional technical documents, systematic reviews, and related articles were hand selected based on relevance and the need to provide a comprehensive analysis. For any systematic review, all relevant articles cited in the systematic review were separately reviewed to ensure consistency with the systematic review conclusions.

All articles retrieved by the search terms were first reviewed by title, and if they appeared relevant, by abstract. Articles which were relevant after abstract review were reviewed in full, and selections were prioritized based on the quality of the study, relevance to one or more of the CDC criteria described in Table 1 , and impact of the findings, with priority going to articles that had undergone peer review. A summary of the process is shown in Figure 1 : Overview of Article Selection Process.

Ultimately, 31 papers were selected to include in this review. Summaries of the decontamination technology, parameters utilized, and conclusions of these papers are shown in Table 4 , Table 5 , and Table 6 for HPGP, aHP, and vHP respectively. 

Saini et al. studied the efficacy of a 7-8% hydrogen peroxide solution stabilized with silver nitrate using the SATEJ Plus (SATEJ Plus, Ahmedabad, India). After 15 repeated decontamination cycles, no physical tears, deformity, or change in droplet permeability were noted. Upon verification with a scanning electron microscope (SEM), no damage to or change in fiber thickness was observed. In addition, there was no noted change in user comfort. 12 smegmatis colony-forming units following a 10 minute aHP cycle with the Satej Plus Machine. 12 John et al. found a 6 log reduction of G. stearothermophilus spores and bacteriophage MS2 using the Altapure system. 13 However, some studies have also raised concerns that aHP may not be effective at eliminating some pathogens, particularly Mycobacterium tuberculosis. Aureus, aerobic spore bearers, skin flora, coliforms, and a 6 log reduction in C. difficile. 27 When Fu et al. tested vHP using the Bioquell Clarus R system, they found that it inactivated 90% of the 6 log and 95% of the 4 log G. stearothermophilus biological indicators. It obtained a >6 log reduction on 55% of A. baumannii, 82% of MRSA, and 100% of C. difficile test discs, with most of the recoverable bacteria requiring a broth culture, likely due to low levels of remaining contamination. When simulated soiling was added, a 4-6 log reduction was still achieved for MRSA and the rate of A. baumannii and C. difficile inactivation were not affected. 28 on N95s using a Bioquell Z Vaporizer. While this did not represent a complete elimination of all viral RNA from the respirators, the authors note the inoculum dose utilized was likely much higher than a healthcare worker would encounter in a clinical environment. 20 Kahnert et al. showed that a Steris VHP1001 vHP system (STERIS V-PRO, STERIS Corporation, OH, USA) was effective against M. tuberculosis, resulting in a >6 log reduction of colony forming units. 31 In terms of other viral inactivity, Tuladhar et al. demonstrated that using the BONECO 7131 (BONECO North America Corp., Encino, CA) with 12% H2O2 to achieve a 126 ppm concentration of H2O2 achieved greater than 4 log reduction of viability of poliovirus, rotavirus, adenovirus, and murine norovirus 1. They also showed a greater than 2 log reduction of influenza A, the most they were able to show due to their low-titer sample. 32

Studies have demonstrated vHP to be more effective than aHP in viral and bacterial reduction. showing vHP's effectiveness against MRSA, additional studies may be needed to determine the best organisms to use as surrogates to confirm decontamination has occurred. 27 vHP and HPGP have been shown to effectively decontaminate N95 masks of SARS-CoV-2 and viral surrogates such as P. phage Phi-6, which has not been shown for aerosolized hydrogen peroxide decontamination methods (Oral, Unpublished Data). 23, 4, 25, 5, 20 However, Wigginton noted that there is currently no FDA specified application medium for testing efficacy of viral decontamination and found that the deposition solution they used affected their results. 5 The variability in results from different testing methodologies highlights the need for a testing procedure for biological inactivation that will enable comparison across technology types with biologically comparable pathogens applied and cultured in a standardized fashion. In addition to culture method, factors such as temperature, humidity, and inoculation size must be controlled, as Otter et al. found that variations resulted in "large standard deviations between cycles" in their study utilizing the Clarus R (Bioquell UK Ltd., Andover, Hamphsire, United Kingdom). 34 Ultimately, it is important that the testing procedures be validated to ensure that they provide an accurate representation of the contamination FFRs will experience in the clinical environment.

Some studies have also shown that aHP is not capable of eliminating some pathogens, including M. tuberculosis, whereas vHP has been shown to achieve a >6 log reduction. 27, 31 No studies investigating HPGP's ability to inactivate M. tuberculosis were found during by our review.

Studies have also shown that aHP's efficacy can vary with distance from the unit, something not seen with vHP as it saturates the treatment areas. 29, 28 Integrity of FFRs N95 respirators have been shown to retain fit after 20 rounds of vHP, while fit testing after aHP decontamination has only been studied for up to 10 Institute's report (Battelle Memorial Institute, Technical Report). 36 The variation in number of donnings and wear time between models before fit failure was also noted by Lieu et al., who suggested that the across the board recommendations for respirator reuse may not sufficiently account for differences between models and brands. 24 Levine et al. also found differences between different N95 models, both in the number of times they would pass fit testing post-vHP decontamination with the STERIS Victory (STERIS Corporation, OH, USA), as well as their ability to pass fit test post-decontamination when tested by a different wearer, a scenario which would likely occur if respirators are collected and redistributed to other healthcare workers under Tier 1 usage. 22 Recognizing these concerns, the FDA reissued a number of its EUAs, specifying that respirators may only be decontaminated for reuse a maximum of 4 times. 37

With respect to HPGP, although much of the data available is not peer reviewed, multiple studies have shown that HPGP may degrade the integrity of the respirators, damaging both the filter and impairing the fit. These studies directly compared HPGP to vHP and showed that vHP maintained its filtration efficiency and fit significantly longer than the HPGP, (Kumar, Chen, Unpublished Data). 6 As such, aHP and vHP are likely much more viable FFR decontamination options than HPGP.

Safety aHP has been shown to be safe in domains of residual H2O2 on the surface of the respirator. 23 It also offers the advantage of using a lower level of H2O2 than comparable methods, such as vHP systems, most of which concentrations of 30-59% H2O2. Using the Altapure AP-4 aHP with peracetic acid, John et al. found that H2O2 had dissipated to 0.0 ppm within 60 minutes of offgassing and the peracetic acid was undetectable within 20 minutes. 13 Unpublished data by Derr et al. found that H2O2 was less than <0.5 ppm, within permitted levels, after treatment.

However, many aHP solutions contain silver cations or peracetic acid, requiring additional studies to determine if any toxic residues or off-gassing post-decontamination could cause harm to the wearer (Derr, Unpublished Data).

In addition to additives, hydrogen peroxide can be hazardous and has a short-term exposure limit (STEL) for hydrogen peroxide of 2 ppm as a 15-min time weighted average. One of the purported advantages of aHP is that the lower concentration of H2O2 reduces safety concerns.

However, Fu et al. showed that system design considerations such as inadequate door sealing resulted in increased hydrogen peroxide exposure potential. 28 Another potential concern about vHP is that the higher concentrations of H2O2 could worsen potential off-gassing from the treated respirators and create a hazard to the wearer. However, data does not appear to support these concerns as Schwartz et al. measured the H2O2 level in the room with off-gassing respirators, finding H2O2 was undetectable after 4 hours. 19 Oral et al. also was unable to detect H2O2 4.5 hours after vHP treatment and Wigginton et al. found no H2O2 off-gassing from the N95s after vHP treatment. (Oral, Wigginton, Unpublished Data) 5 Salter et al. found that even after 18 hours, the treated respirators retained some H2O2. However, because it is so slow to evaporate, they concluded that the residual amount was unlikely to pose a significant health hazard. 38

Overall, vHP has the most evidence supporting its efficacy for use in FFR decontamination. It has been shown to be more effective at inactivating bacteria and viruses than aHP, and it does not degrade the filtration efficiency of the respirators as HPGP does. Compared to aHP, FFR filter performance and fit have been validated at more decontamination cycles, indicating the need for further aHP studies for adequate comparison. However, studies have raised significant concerns regarding the ability of respirators to maintain fit in the clinical setting, regardless of decontamination technique, potentially limiting the number of cycles respirators can be reused.

Additionally, lack of consistency in testing of efficacy of microbial inactivation across the technologies makes both comparison between, and real-world validation of function difficult, indicating the need for standardization of testing and validation protocols. As many of these technologies will be utilized to decontaminate equipment in unique space such as a closet or hospital room rather than a standardized compartment that would be attached to the machine, the applicability of testing to real application must be validated. This includes testing in or controlling the specific operating conditions such as compartment material, humidity, temperature, and load volume, in addition to the types of respirators at varying soil levels the system will eventually decontaminate for reuse.

Furthermore, variables such as cycle time, startup and operational costs, and training are important considerations for any FFR decontamination system, but these are beyond the scope of this review. Importantly, to validate safe reuse, public health surveillance to track COVID-19 transmission rates in healthcare workers using FFRs that have been decontaminated should be conducted.

An interactive web-based dashboard to track COVID-19 in real time

Shortage of Personal Protective Equipment Endangering Health Workers Worldwide

COVID-19) Decontamination and Reuse

Decontamination System EUAs for Personal Protective Equipment

Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden Reduction Systems for Surgical Masks and Respirators During the Coronavirus Disease 2019 (COVID19) Public Health Emergency Guidance for Industry and Food and Drug Administration Staff

Effect of Decontamination on the Filtration Efficiency of Two Filtering Facepiece Respirator Models

Evaluation of five decontamination methods for filtering facepiece respirators

Evaluation of multiple (3-Cycle) decontamination processing for filtering facepiece respirators

Validation of N95 filtering facepiece respirator decontamination methods available at a large university hospital. medRxiv. Unpublished Results

Addressing decontaminated respirators: Some methods appear to damage mask integrity and protective function

Transmission of aerosols through pristine and reprocessed N95 respirators. medRxiv. Unpublished Results

Development of a highly effective low-cost vaporized hydrogen peroxide-based method for disinfection of personal protective equipment for their selective reuse during pandemics

Scalable in-hospital decontamination of N95 filtering face-piece respirator with a peracetic acid room disinfection system

Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators

Vapor H2O2 sterilization as a decontamination method for the reuse of N95 respirators in the COVID-19 emergency. medRxiv. Unpublished Results

N95 reprocessing by low temperature sterilization with 59% vaporized hydrogen peroxide during the 2020 COVID-19 pandemic

N95 Mask Decontamination using Standard Hospital Sterilization Technologies. medRxiv. Unpublished Results

Aerosolized Hydrogen Peroxide Decontamination of N95 Respirators, with Fit-Testing and Virologic Confirmation of Suitability for Re-Use During the COVID-19 Pandemic. medRxiv. Unpublished Results

Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2

Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity

Assessment of N95 respirator decontamination and re-use for SARS-CoV-2. medRxiv

Use, reuse or discard: quantitatively defined variance in the functional integrity of N95 respirators following vaporized hydrogen peroxide decontamination during the COVID-19 pandemic

Efficacy of a multi-purpose high level disinfection cabinet against Candida auris and other health careassociated pathogen

Impact of extended use and decontamination with vaporized hydrogen peroxide on N95 respirator fit

Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: Impact on the reutilization of disposable devices

Effectiveness of ultraviolet-c light and a high-level disinfection cabinet for decontamination of n95 respirators. Pathog Immun

Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: Focus on clinical trials

Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems

Quantifying Glosair™ 400 efficacy for surface disinfection of American Type Culture Collection strains and microorganisms recently isolated from intensive care unit patients

Hydrogen Peroxide Vapor sterilization of N95 respirators for reuse

Decontamination with vaporized hydrogen peroxide is effective against Mycobacterium tuberculosis

Virucidal efficacy of hydrogen peroxide vapour disinfection

Methicillin-resistant Staphylococcus aureus is more resistant to vaporized hydrogen peroxide than commercial Geobacillus stearothermophilus biological indicators

Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor

Such as N95 Respirators, in the United States -Considerations.; Technical Bulletin

Correlation between N95 Extended Use and Reuse and Fit Failure in an Emergency Department

37. Food and Drug Administration. Coronavirus (COVID-19) Update

Analysis of residual chemicals on filtering facepiece respirators after decontamination

Vaporized hydrogen peroxide has the most data supporting its use for decontamination.  Hydrogen peroxide gas plasma can cause a degradation in filtration efficiency.  Respirator fit failure may limit reuse independent of decontamination method.  Consistent standards for testing microbial inactivation should be developed